A recent study conducted by Eick et al[41] evaluated the levels of several biomarkers, including calprotectin, IL-1β, matrix metalloprotease (MMP)-8, MMP-1, and tissue inhibitor of MMP-1, in the GCF of periodontitis patients before and after SRP. This evidence concerns the gene MMP1 and periodontitis.